Suppr超能文献

脑炎疫苗诱导的针对新冠病毒的交叉保护可能是一些国家死亡率相对较低的原因。

Cross-Protection Induced by Encephalitis Vaccines against COVID-19 Might be a Reason for Relatively Lower Mortality Rate in Some Countries.

作者信息

Katoh Shojiro, Obayashi Toshihiko, Ganesh Jegatheesan Saravana, Iwasaki Masaru, Preethy Senthilkumar, Abraham Samuel Jk

机构信息

Edogawa Evolutionary Lab of Science, Edogawa Hospital Campus, 2-24-18, Higashi-Koiwa, Edogawa, Tokyo 133-0052, Japan.

Edogawa Hospital, 2-24-18, Higashi-Koiwa, Edogawa, Tokyo 133-0052, Japan.

出版信息

Arch Acad Emerg Med. 2020 Apr 21;8(1):e54. eCollection 2020.

Abstract

COronaVIrus Disease 2019 (COVID-19) is an on-going pandemic attributed to a novel virus named SARS-CoV-2. Comparing the statistics of incidence and death rates between nations reveals that there is discrepancy amongst countries in these regards, even between countries that share borders. We herein present information from the literature indicating how cross-protection against COVID-19 conferred by the encephalitis vaccine could be the reason for lower fatality rate in the countries where immunization against encephalitis is widespread or included in national programs. This may pave the way for arriving at efficient prevention strategies as well as vaccine development.

摘要

2019冠状病毒病(COVID-19)是由一种名为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新型病毒引起的正在流行的疾病。比较各国的发病率和死亡率统计数据发现,在这些方面各国之间存在差异,即使是接壤国家之间也是如此。我们在此提供文献中的信息,表明流行性乙型脑炎疫苗对COVID-19的交叉保护作用可能是流行性乙型脑炎免疫接种普遍或纳入国家计划的国家死亡率较低的原因。这可能为制定有效的预防策略以及疫苗研发铺平道路。

相似文献

2
Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.
PLoS Negl Trop Dis. 2019 Aug 2;13(8):e0007601. doi: 10.1371/journal.pntd.0007601. eCollection 2019 Aug.
4
Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice.
Appl Microbiol Biotechnol. 2019 Jun;103(12):4977-4986. doi: 10.1007/s00253-019-09798-9. Epub 2019 Apr 29.
5
BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?
Front Pharmacol. 2020 Jul 9;11:1050. doi: 10.3389/fphar.2020.01050. eCollection 2020.
6
Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
Vaccine. 2013 Dec 17;32(1):119-23. doi: 10.1016/j.vaccine.2013.10.055. Epub 2013 Oct 28.
8
Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example.
Saudi Pharm J. 2020 Jul;28(7):898-902. doi: 10.1016/j.jsps.2020.05.005. Epub 2020 May 22.
9
Japanese encephalitis vaccines--needs, flaws and achievements.
Biol Chem. 2008 May;389(5):547-50. doi: 10.1515/bc.2008.062.
10
Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
PLoS Negl Trop Dis. 2016 Aug 25;10(8):e0004936. doi: 10.1371/journal.pntd.0004936. eCollection 2016 Aug.

本文引用的文献

1
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2.
Int J Infect Dis. 2020 May;94:55-58. doi: 10.1016/j.ijid.2020.03.062. Epub 2020 Apr 3.
2
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
3
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
4
The COVID-19 epidemic.
Trop Med Int Health. 2020 Mar;25(3):278-280. doi: 10.1111/tmi.13383. Epub 2020 Feb 16.
7
Sense of life worth living (ikigai) and mortality in Japan: Ohsaki Study.
Psychosom Med. 2008 Jul;70(6):709-15. doi: 10.1097/PSY.0b013e31817e7e64. Epub 2008 Jul 2.
8
Japanese encephalitis.
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):405-15. doi: 10.1136/jnnp.68.4.405.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验